Clinical Trials for CAR T Cells at Bezos Family Immunotherapy Clinic
David G. Maloney, MD, PhD, medical director of immunotherapy at the Seattle Cancer Care Alliance and member of Fred Hutchinson Research Center, discusses the clinical trials that are currently investigating chimeric antigen receptor T cells at the Bezos Family Immunotherapy Clinic at Fred Hutchinson.
David G. Maloney, MD, PhD, medical director of immunotherapy at the Seattle Cancer Care Alliance and member of Fred Hutchinson Research Center, discusses the clinical trials that are currently investigating chimeric antigen receptor (CAR) T cells at the Bezos Family Immunotherapy Clinic at Fred Hutchinson.
There are 18 different clinical trials actively looking at CAR T cells in a variety of settings. In breast and lung cancers, Maloney says they are testing CAR T cells against ROR1, which is exciting. In multiple myeloma, multiple companies are involved in BCMA CAR T cells trials.
Acalabrutinib/Obinutuzumab Shows Improved PFS in Treatment-Naive CLL
April 10th 2024In an interview with Targeted Oncology, Jeff Sharman, MD, discussed the results of the ELEVATE-TN trial of acalabrutinib with or without obinutuzumab at 74.5 months of follow-up among patients with chronic lymphocytic leukemia.
Read More
